Also – we’re hiring another reporter for the team! Are you a journalist looking to dig deep on digital health, break news, and make sense of what’s ahead for the industry? Be sure to apply here!
A pharmacist fills a syringe to prepare a dose of the Pfizer-BioNTech Covid-19 vaccine for front-line health care workers at a vaccination site at Torrance Memorial Medical Center on December 19, 2020 in Torrance, California. Patrick T. Fallon / AFP via Getty Images
The results - while not as high as Pfizer and Moderna's - come with some big questions. For one, having only one dose could be a game-changer. J&J shared that its vaccine was 85% effective at preventing severe disease, across all variants, which would be a big help in curbing the pandemic.
At a mass vaccination site set up in a California Six Flags, a nurse administers the COVID vaccine. The state has delivered 45% of its allotted vaccines, compared to North Dakota's 84% and South Dakota's 75%. Jae C. Hong/AP Photo
For states and cities with bigger populations, she found there are two big takeaways from North Dakota and South Dakota's experiences. Collaboration is key, and so is keeping the rollout system centralized.
It's a move most Wall Street analysts are cheering on, saying Walgreens "nailed" the choice for a successor to Stefano Pessina who will stay on as executive chairman.
Shelby Livingston has a full look at what analysts think is ahead for the company with the pick.
Last Friday, Shelby had a chat with Humana CEO Bruce Broussard.
Broussard told her about competing with some of the health-insurance startups taking on the red-hot Medicare Advantage market, like Oscar and Devoted.
Humana for its part has its own answer: a new venture called Author. It launched in 2021 in South Carolina, and already has 15,000 members, Broussard told Shelby.
Speaking of the insurance upstarts, Shelby and the graphics team here at Insider took a closer look at Medicare Advantage enrollment heading into 2021.
(It's pretty striking to see the enrollment numbers for giants like UnitedHealthcare stacked next to some of the tiny younger players.)
As part of Shelby's conversation with Broussard, they discussed what led Humana to invest heavily in primary care. The conversation turned into one about the future of health insurers, medicine, and Humana itself.
Tech giants are keeping busy, as Blake Dodge has been reporting over the past few weeks.
That's especially the case for companies as part of the Alphabet umbrella. She and Alphabet reporter Hugh Langley teamed up over the past week on some dispatches from Google's parent company.
With that all in mind, I wanted to let you know about an event Megan is moderating on February 10 at 3 p.m. ET. She'll be talking to top healthcare VCs about the year ahead for startups trying to make a dent in the $3.8 trillion healthcare industry.
